Practical algorithms for amyloid β probability in subjective or mild cognitive impairment

por Maserejian, Nancy, Bian, Shijia, Wang, Wenting, Jaeger, Judith, Syrjanen, Jeremy A., Aakre, Jeremiah, Jack, Clifford R., Mielke, Michelle M., Gao, Feng
Publicado 2019

Association between physical activity and longitudinal change in body mass index in middle-aged and older adults

por Cleven, Laura, Syrjanen, Jeremy A., Geda, Yonas E., Christenson, Luke R., Petersen, Ronald C., Vassilaki, Maria, Woll, Alexander, Krell-Roesch, Janina
Publicado 2023

Quantity and quality of mental activities and the risk of incident mild cognitive impairment

por Krell-Roesch, Janina, Syrjanen, Jeremy A., Vassilaki, Maria, Machulda, Mary M., Mielke, Michelle M., Knopman, David S., Kremers, Walter K., Petersen, Ronald C., Geda, Yonas E.
Publicado 2019

Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging

por Krell‐Roesch, Janina, Syrjanen, Jeremy A., Machulda, Mary M., Christianson, Teresa J., Kremers, Walter K., Mielke, Michelle M., Knopman, David S., Petersen, Ronald C., Vassilaki, Maria, Geda, Yonas E.
Publicado 2021

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures

por Mielke, Michelle M., Syrjanen, Jeremy A., Blennow, Kaj, Zetterberg, Henrik, Vemuri, Prashanthi, Skoog, Ingmar, Machulda, Mary M., Kremers, Walter K., Knopman, David S., Jack, Clifford, Petersen, Ronald C., Kern, Silke
Publicado 2019

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status

por Campbell, Michelle R., Ashrafzadeh‐Kian, Susan, Petersen, Ronald C., Mielke, Michelle M., Syrjanen, Jeremy A., van Harten, Argonde C., Lowe, Val J., Jack, Clifford R., Bornhorst, Joshua A., Algeciras‐Schimnich, Alicia
Publicado 2021

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes

por Marks, Jordan D., Syrjanen, Jeremy A., Graff-Radford, Jonathan, Petersen, Ronald C., Machulda, Mary M., Campbell, Michelle R., Algeciras-Schimnich, Alicia, Lowe, Val, Knopman, David S., Jack, Clifford R., Vemuri, Prashanthi, Mielke, Michelle M.
Publicado 2021

Association of non-exercise physical activity in mid- and late-life with cognitive trajectories and the impact of APOE ε4 genotype status: the Mayo Clinic Study of Aging

por Krell-Roesch, Janina, Syrjanen, Jeremy A., Vassilaki, Maria, Barisch-Fritz, Bettina, Trautwein, Sandra, Boes, Klaus, Woll, Alexander, Kremers, Walter K., Machulda, Mary M., Mielke, Michelle M., Knopman, David S., Petersen, Ronald C., Geda, Yonas E.
Publicado 2019

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment

por Pink, Anna, Krell‐Roesch, Janina, Syrjanen, Jeremy A., Vassilaki, Maria, Lowe, Val J., Vemuri, Prashanthi, Stokin, Gorazd B., Christianson, Teresa J., Kremers, Walter K., Jack, Clifford R., Knopman, David S., Petersen, Ronald C., Geda, Yonas E.
Publicado 2021

Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study

por Krell‐Roesch, Janina, Zaniletti, Isabella, Syrjanen, Jeremy A., Kremers, Walter K., Algeciras‐Schimnich, Alicia, Dage, Jeffrey L., van Harten, Argonde C., Fields, Julie A., Knopman, David S., Jack, Clifford R., Petersen, Ronald C., Vassilaki, Maria, Geda, Yonas E.
Publicado 2023

Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging

por Krell-Roesch, Janina, Syrjanen, Jeremy A., Bezold, Jelena, Trautwein, Sandra, Barisch-Fritz, Bettina, Boes, Klaus, Woll, Alexander, Forzani, Erica, Kremers, Walter K., Machulda, Mary M., Mielke, Michelle M., Knopman, David S., Petersen, Ronald C., Vassilaki, Maria, Geda, Yonas E.
Publicado 2021

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment

por Vassilaki, Maria, Syrjanen, Jeremy A., Krell-Roesch, Janina, Graff-Radford, Jonathan, Vemuri, Prashanthi, Scharf, Eugene L., Machulda, Mary M., Fields, Julie A., Kremers, Walter K., Lowe, Val J., Jack, Clifford R., Knopman, David S., Petersen, Ronald C., Geda, Yonas E.
Publicado 2023

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline

por Pink, Anna, Krell‐Roesch, Janina, Syrjanen, Jeremy A., Christenson, Luke R., Lowe, Val J., Vemuri, Prashanthi, Fields, Julie A., Stokin, Gorazd B., Kremers, Walter K., Scharf, Eugene L., Jack, Clifford R., Knopman, David S., Petersen, Ronald C., Vassilaki, Maria, Geda, Yonas E.
Publicado 2023

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging

por Krell-Roesch, Janina, Vassilaki, Maria, Mielke, Michelle M., Kremers, Walter K., Lowe, Val J., Vemuri, Prashanthi, Machulda, Mary M., Christianson, Teresa J., Syrjanen, Jeremy A., Stokin, Gorazd B., Butler, Lesley M., Traber, Martin, Jack, Clifford R., Knopman, David S., Roberts, Rosebud O., Petersen, Ronald C., Geda, Yonas E.
Publicado 2019

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

por Murray, Melissa E., Moloney, Christina M., Kouri, Naomi, Syrjanen, Jeremy A., Matchett, Billie J., Rothberg, Darren M., Tranovich, Jessica F., Sirmans, Tiffany N. Hicks, Wiste, Heather J., Boon, Baayla D. C., Nguyen, Aivi T., Reichard, R. Ross, Dickson, Dennis W., Lowe, Val J., Dage, Jeffrey L., Petersen, Ronald C., Jack, Clifford R., Knopman, David S., Vemuri, Prashanthi, Graff-Radford, Jonathan, Mielke, Michelle M.
Publicado 2022